Pre-market
Other
Reported value range
Not reported

Gujrathi Sheila Chief Strategy Officer

Transaction date Oct 23, 2026
Public filing date Oct 27, 2026
Filing lag Filed 4 days later

BOLT daily price context

No linked price history

This asset is not matched to a market-data symbol.

Source details

Reported owner
Not disclosed
Source asset code
Derivative
Security
Series D Preferred Stock on Common Stock
Quantity / price
2763.83 shares
SEC ownership
Direct
Transaction code
J
Form
4
Filing identifier
0001193125-26-434468
Filing cohort

Transactions in this filing

Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Bolt Biotherapeutics, Inc. BOLT Other Oct 23, 2026 Not reported
Bolt Biotherapeutics, Inc. BOLT Current Other Oct 23, 2026 Not reported
Bolt Biotherapeutics, Inc. BOLT Award Oct 23, 2026 $0
Bolt Biotherapeutics, Inc. BOLT Award Oct 23, 2026 $0